Skip to content
Disclosery

Broadfin Capital, LLC

Follow

13F filer, CIK 1511901, New York, NY

Broadfin Capital, LLC reported $760,541,000 across 50 holdings for the quarter ended 2018-12-31, in a 13F-HR filed 2019-02-14. Its ten largest share positions make up 53.68% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001511901-19-000001

Period
2018-12-31
Reported value
$761M
Holdings
50
Top 10 weight
53.68%
New
13
Sold out
13

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NEVRO CORPnew+744,415$28.9M
TESARO INCadded+337,519$25.1M
DXCMadded+155,700$18.7M
ACRSnew+1,877,502$13.9M
INCYnew+183,300$11.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CORIUM INTL INCexited-2,368,557-$22.5M
TNDMreduced-483,979-$18.4M
PACBexited-2,493,021-$13.5M
XENEexited-895,553-$11.8M
HORIZON PHARMA PLCexited-410,532-$8.04M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2018

Share positions as resolved from 13F-HR 0001511901-19-000001, largest first. % of portfolio is the value over $485,206,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 912,987 shares; 2018Q2: 4,146,605 shares; 2018Q3: 4,894,361 shares; 2018Q4: 5,951,153 shares 5,951,153$52.7M10.85%+1,056,792Timeline
TESARO INCTESARO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 104,700 shares; 2018Q4: 442,219 shares 442,219$32.8M6.77%+337,519
NEVRO CORPNEVRO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 744,415 shares 744,415$28.9M5.97%new
ARATANA THERAPEUTICS INCARATANA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,294,426 shares; 2018Q2: 4,294,426 shares; 2018Q3: 4,083,135 shares; 2018Q4: 4,083,135 shares 4,083,135$25M5.16%0
RETROPHIN INCRETROPHIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,178,226 shares; 2018Q2: 1,048,693 shares; 2018Q3: 938,214 shares; 2018Q4: 1,016,114 shares 1,016,114$23M4.74%+77,900
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,135,203 shares; 2018Q2: 1,417,121 shares; 2018Q3: 1,328,424 shares; 2018Q4: 2,614,468 shares 2,614,468$22.3M4.6%+1,286,044
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 24,200 shares; 2018Q4: 179,900 shares 179,900$21.6M4.44%+155,700Timeline
ZOGENIX INC.ZOGENIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 537,380 shares; 2018Q2: 622,380 shares; 2018Q3: 657,898 shares; 2018Q4: 535,998 shares 535,998$19.5M4.03%-121,900
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,656,720 shares; 2018Q2: 1,494,520 shares; 2018Q3: 2,053,991 shares; 2018Q4: 1,947,541 shares 1,947,541$18.4M3.78%-106,450
BIODELIVERY SCIENCES INTL INBIODELIVERY SCIENCES INTL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,278,819 shares; 2018Q2: 4,278,819 shares; 2018Q3: 4,375,066 shares; 2018Q4: 4,375,066 shares 4,375,066$16.2M3.34%0
SOCIETAL CDMO INCSOCIETAL CDMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,236,025 shares; 2018Q2: 2,048,025 shares; 2018Q3: 2,048,025 shares; 2018Q4: 2,048,025 shares 2,048,025$14.5M3%0
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 1,877,502 shares 1,877,502$13.9M2.86%newTimeline
STRONGBRIDGE BIOPHARMA PLCSTRONGBRIDGE BIOPHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,793,752 shares; 2018Q2: 2,340,649 shares; 2018Q3: 2,563,096 shares; 2018Q4: 2,821,722 shares 2,821,722$12.6M2.61%+258,626
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 6,812,764 shares; 2018Q2: 6,772,764 shares; 2018Q3: 5,136,264 shares; 2018Q4: 6,268,298 shares 6,268,298$12M2.48%+1,132,034Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 183,300 shares 183,300$11.7M2.4%newTimeline
NANOSTRING TECHNOLOGIES INCNANOSTRING TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 850,000 shares; 2018Q4: 720,600 shares 720,600$10.7M2.2%-129,400
QUOTIENT LTDQUOTIENT LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 439,700 shares; 2018Q3: 804,700 shares; 2018Q4: 1,697,582 shares 1,697,582$10.4M2.14%+892,882
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 720,529 shares; 2018Q2: 3,249,829 shares; 2018Q3: 4,463,829 shares; 2018Q4: 4,226,077 shares 4,226,077$10.1M2.08%-237,752Timeline
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 80,100 shares; 2018Q3: not reported; 2018Q4: 240,909 shares 240,909$9.89M2.04%new
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,673,247 shares; 2018Q2: 4,623,247 shares; 2018Q3: 4,623,247 shares; 2018Q4: 3,444,147 shares 3,444,147$9.37M1.93%-1,179,100
IARTINTEGRA LIFESCIENCES HLDGS CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 298,424 shares; 2018Q2: 163,424 shares; 2018Q3: 196,572 shares; 2018Q4: 196,572 shares 196,572$8.87M1.83%0Timeline
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,443,948 shares; 2018Q2: 1,020,178 shares; 2018Q3: 357,672 shares; 2018Q4: 200,000 shares 200,000$8.48M1.75%-157,672
INTERSECT ENT INCINTERSECT ENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 234,200 shares; 2018Q4: 287,900 shares 287,900$8.11M1.67%+53,700
AVADEL PHARMACEUTICALS, PLCAVADEL PHARMACEUTICALS, PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,624,663 shares; 2018Q2: 2,724,663 shares; 2018Q3: 2,792,773 shares; 2018Q4: 3,102,673 shares 3,102,673$8.01M1.65%+309,900
SIERRA ONCOLOGY INCSIERRA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 2,106,589 shares; 2018Q3: 4,090,344 shares; 2018Q4: 4,880,327 shares 4,880,327$6.44M1.33%+789,983
ALEXION PHARMACEUTICALS INCALEXION PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 58,700 shares 58,700$5.71M1.18%new
STRATA SKIN SCIENCES INCSTRATA SKIN SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 203,346 shares; 2018Q2: 2,943,819 shares; 2018Q3: 2,181,363 shares; 2018Q4: 2,171,363 shares 2,171,363$5.65M1.16%-10,000
VRAYQVIEWRAY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 250,000 shares; 2018Q4: 866,500 shares 866,500$5.26M1.08%+616,500Timeline
SOL GEL TECHNOLOGIESSOL GEL TECHNOLOGIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 647,700 shares; 2018Q2: 647,700 shares; 2018Q3: 847,700 shares; 2018Q4: 847,700 shares 847,700$5.1M1.05%0
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDINQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 129,300 shares 129,300$4.78M0.99%new
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 72,100 shares; 2018Q3: 51,000 shares; 2018Q4: 51,000 shares 51,000$4.67M0.96%0Timeline
OPTINOSE INCOPTINOSE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 710,600 shares 710,600$4.41M0.91%new
NEOS THERAPEUTICS INCNEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 2,618,819 shares 2,618,819$4.32M0.89%new
RVLPQRVL PHARMACEUTICALS PLC ORDINAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 528,571 shares 528,571$4.1M0.84%newTimeline
TELIGENT INC NEWTELIGENT INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,690,794 shares; 2018Q2: 2,999,817 shares; 2018Q3: 3,052,852 shares; 2018Q4: 2,823,383 shares 2,823,383$3.87M0.8%-229,469
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 570,598 shares; 2018Q3: 573,079 shares; 2018Q4: 89,100 shares 89,100$3.38M0.7%-483,979Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 658,900 shares; 2018Q2: not reported; 2018Q3: 132,600 shares; 2018Q4: 190,000 shares 190,000$3.31M0.68%+57,400Timeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,581,416 shares; 2018Q2: 519,787 shares; 2018Q3: 291,213 shares; 2018Q4: 119,294 shares 119,294$3.09M0.64%-171,919Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 150,000 shares; 2018Q4: 143,129 shares 143,129$2.83M0.58%-6,871Timeline
DOVA PHARMACEUTICALS INCDOVA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 351,800 shares 351,800$2.67M0.55%new
KALA BIO INC COMKALA BIO INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 681,239 shares; 2018Q2: 598,586 shares; 2018Q3: 346,083 shares; 2018Q4: 339,119 shares 339,119$1.66M0.34%-6,964
EIGER BIOPHARMACEUTICALS INCEIGER BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 143,300 shares 143,300$1.46M0.3%new
IDERA PHARMACEUTICALS INCIDERA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 629,340 shares; 2018Q4: 486,604 shares 486,604$1.35M0.28%-142,736
NOVELION THERAPEUTICS INCNOVELION THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,948,554 shares; 2018Q2: 1,948,554 shares; 2018Q3: 1,948,554 shares; 2018Q4: 1,229,301 shares 1,229,301$1.03M0.21%-719,253
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 1,111,112 shares; 2018Q3: 669,812 shares; 2018Q4: 449,585 shares 449,585$1.03M0.21%-220,227Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput700,000$175Mnew
XBISPDR SERIES TRUST S&P BIOTECHput700,000$50.2M+540,000
TESARO INCTESARO INC COMcall325,000$24.1M+200,000
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USD COMcall350,000$14.4M+200,000
NEVRO CORPNEVRO CORP COMcall300,000$11.7Mnew

Sold out in Q4 2018

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IWMISHARES TR400,000$67.4Mput
AMARIN CORP PLCAMARIN CORP PLC1,455,000$23.7Mcall
CORIUM INTL INCCORIUM INTL INC2,368,557$22.5Mshares
PACBPACIFIC BIOSCIENCES CALIF IN2,493,021$13.5Mshares
XENEXENON PHARMACEUTICALS INC895,553$11.8Mshares
HORIZON PHARMA PLCHORIZON PHARMA PLC410,532$8.04Mshares
ANGOANGIODYNAMICS INC289,035$6.28Mshares
ALNYALNYLAM PHARMACEUTICALS INC62,200$5.44Mshares
PERNIX THERAPEUTICS HLDGS INPERNIX THERAPEUTICS HLDGS IN15,000,000$3.38Mshares
HRTXHERON THERAPEUTICS INC100,000$3.17Mcall
SCYNEXIS INC COM NEWSCYNEXIS INC COM NEW1,885,904$2.26Mshares
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL CO100,000$2.01Mcall
ONCOMED PHARMACEUTICALS INC…ONCOMED PHARMACEUTICALS INC COM200,000$424Kshares

How Q4 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001511901-19-000001 base2019-02-14acceptance time not in the bulk data set